| - Industry | - Sector | Mr. Ajay Bhardwaj B.Tech., M.S CEO | XNSE Exchange | Y0145S115 CUSIP |
| India Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Anthem Biosciences Limited is a distinguished contract research, development, and manufacturing organization (CRDMO) located in Bengaluru, India. The company is renowned for its extensive and integrated services that cover the full range of drug discovery, development, and commercial manufacturing processes. Catering primarily to both innovative biotech companies and major pharmaceutical corporations, Anthem Biosciences is particularly noted for its proficiency in the manufacturing of complex, fermentation-based active pharmaceutical ingredients (APIs). This includes a diverse array of products such as probiotics, enzymes, peptides, vitamin analogues, nutritional actives, and biosimilars. Armed with advanced research and development facilities, Anthem manages nearly 200 active projects at different clinical and commercial stages and boasts a portfolio of granted and pending patents worldwide. Serving a diverse client base across 44 countries and over 425 customers, the company is steadfast in its commitment to high standards of quality, compliance, and innovation. Anthem's role as a strategic partner in the life sciences industry is strengthened by a team of dedicated scientists and engineers who are adept at addressing critical challenges encountered in both biological and chemical drug development, reinforcing the company’s reputation as a reliable provider of comprehensive pharmaceutical solutions.
Anthem specializes in manufacturing complex, fermentation-based APIs. These include essential components like probiotics, enzymes, peptides, and vitamin analogues, which are crucial for various therapeutic applications.
The company develops high-quality probiotic products aimed at enhancing gut health, improving digestion, and supporting overall wellness. These probiotics are designed to meet stringent quality standards, ensuring efficacy and safety.
Anthem produces specialized enzymes that are utilized in numerous biotechnological and pharmaceutical processes. These enzymes play a vital role in various biochemical conversions and are tailored to meet specific client demands.
The company manufactures a range of peptides with diverse applications in drug development and therapeutic treatments, focusing on quality and biological activity to meet the needs of the pharmaceutical market.
Anthem is engaged in the production of vitamin analogues that serve as nutritional supplements or therapeutic agents, addressing the nuanced demands of both consumers and healthcare providers.
The company provides nutritional actives beneficial for health and wellness, incorporating advanced scientific research to create innovative and effective products that meet market needs.
Anthem also develops biosimilars, which are biologic medical products highly similar to already approved reference products, ensuring a cost-effective alternative for patients while maintaining regulatory compliance.
From initial drug discovery through development to commercial manufacturing, Anthem offers end-to-end solutions tailored to their clients’ needs, ensuring a seamless transition across various stages of pharmaceutical product development.